Search Results - "Meddour, Y."

Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes? by Lounici Boudiaf, A., Bouziane, D., Smara, M., Meddour, Y., Haffaf, E.M., Oudjit, B., Chaib Mamouzi, S., Aouichat Bouguerra, S.

“…The zinc transporter 8 (ZnT8) is an islet β-cell secretory granule membrane protein coded by the SLC30A8 gene, identified as a novel autoantigen in human type…”
Get full text

T300A variant of AT16L1 gene in a cohort of Algerian Crohn disease patients by Aida, I., Meddour, Y., Kadiri, H., Smara, M., Bousseloub, A., Kecili, L., Gamar, L., Belhocine, K., Boussafsaf, M.-A., Debzi, N., Aouichat-Bouguerra, S., Chaib, S.

“…The T300A variant is among the most Crohn's disease (CD) associated genetic variants. The aim of our study is to bring a first insight about the contribution…”
Get full text

NOD2/CARD15 and IL23R genetic variability in 204 Algerian Crohn's disease by Meddour, Y, Chaib, S, Bousseloub, A, Kaddache, N, Kecili, L, Gamar, L, Nakkemouche, M, Djidjik, R, Abbadi, M.C, Charron, D, Boucekkine, T.E, Tamouza, R

“…Summary NOD2/CARD15 and IL23R gene variants play an important role in the susceptibility to Crohn's disease (CD). Studies of genotype-phenotype relationship…”
Get full text

Evaluation of the Imatinib Treatment of Patients with Chronic Myeloid Leukemia (CML). a Retrospective Study from Algerian Working Group on CML (GAT-LMC) by Djouadi, K, Bouchakour, A, Taoussi, S, Abad, MT, Ouchenane, Z, Sidi Mansour, N, Abdennebi, N, Harieche, F, Ahmed Nacer, R, Hamladji, RM, Touil, Fz, Hamdi, S, Entasoltane, B, Brahimi, M, Nachi, M, Bekadja, MA, Kerrar, C, Allam, L, Djidjik, O, Boudjerra, N, Belhani, M, Bougherira, S, Grifi, F, Gherras, S, Graine, A, Ait Ali, H, Brahimi, Z, Touati, L, Lakhdari, N, Mehalhal, N, Taibi, K, Touhami, H, Benzineb, B, Mesli, N, Saber Cherif, D, Rahali, C, Mansour, N, Meddour, Y, Chaib, S, Ardjoun, Fz, Maghraoui, F, Hadjeb, S, Zenori, M, Benlazhar, M, Zouaoui, Z, Baghdad, S, Bachiri, A, Lamara, D, Bendjabellah, B, Benakli, M

“…Introduction: The advent of anti-tyrosine kinase has revolutionized the treatment of chronic myeloid leukemia. Indeed, from 2000, the IMATINIB has become…”
Get full text

Epidemiological Approach of Chronic Myeloid Leukemia. Algerian-Tunisian Study by Djouadi, K, Abdennebi, N, Harieche, F, Ahmed Nacer, R, Hamladji, RM, Bouchakour, A, Taoussi, S, Abad, MT, Touil, Fz, Hamdi, S, Bougherira, S, Grifi, F, Kerrar, C, Allam, I, Djidjik, O, Boudjerra, N, Belhani, M, Gherras, S, Graine, A, Ait Ali, H, Entasoltane, B, Brahimi, M, Bekadja, MA, Ben lakhal, R, Meddeb, B, Ouchenane, Z, Sidi Mansour, N, Kacha, F, Tibermacine, F, Saidi, M, Mehalhal, N, Brahimi, Fz, Touati, L, Lakhdari, N, Saber Cherif, D, Meddour, Y, Chaib, S, Ardjoun, Fz, Bellaaj, H, Taibi, K, Touhami, H, Manai, HZ, Benzineb, B, Mesli, N, Maghraoui, A, Hadjeb, S, Zouaoui, Z, Baghdad, S, Bachiri, A, Laatiri, MA, Attari, M, Lamara, D, Bendjabellah, B, Ghedira, H, Ben Youcef, Y, Trabzi, A, Menif, S, Ben Othman, T, Benakli, M

“…Introduction: Chronic myeloid leukemia (CML) accounts for 7%-15% of all leukemias affecting adults. The incidence in Algeria is 0.4/100,000 inhabitants in…”
Get full text

Verrues profuses révélant un syndrome WHIM : à propos d’un cas algérien by Bouregaa, S., Hammadi, H., Meddour, Y., Younsi, F., Timsiline, M., Keniza, H., Salhi, A., Djeridane, A., Ammar-Khodja, A.

“…WHIM est un acronyme qui désigne un syndrome incluant la présence de verrues (Warts), une hypogamma globulinémie (H), des infections bactériennes à répétition…”
Get full text